DEF 14A: Auddia Inc. Seeks Shareholder Approval for Key Capital & Equity Plans

Auddia Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and key capital and equity plan amendments.

Summary

• The 2025 Annual Meeting of Stockholders will be held on September 8, 2025, at 9:30 a.m. Mountain Time, at the company's offices in Boulder, CO.
• The record date for stockholders entitled to vote at the Annual Meeting is July 31, 2025, with 664,959 shares of common stock outstanding.
• Stockholders will vote on five key proposals: electing four director nominees, ratifying Haynie & Company as the independent auditor for fiscal year ending December 31, 2025, authorizing common stock issuance under an amended Equity Line of Credit (ELOC), authorizing common stock issuance related to Series C convertible preferred stock and warrants, and approving an amendment to the 2020 Equity Incentive Plan.
• The board of directors recommends a vote 'FOR' all proposals.
• The proposed ELOC amendment with White Lion Capital, LLC, extends the agreement's expiration from December 31, 2025, to December 31, 2027, and increases the total commitment amount from $10 million to $50 million. As of July 31, 2025, $0.1 million has been issued under the current ELOC.
• The Series C Preferred Stock and Warrants financing, completed on June 30, 2025, generated $750,000 in gross proceeds. It involved issuing 750 shares of Series C convertible preferred stock at $1,000 per share, convertible into common stock at an initial price of $4.77 per share, and Series C Warrants exercisable for 314,466 shares at an initial exercise price of $4.77 per share.
• The Series C Preferred Stock carries a 10% annual dividend, payable quarterly, with the option to pay in common stock or cumulate.
• The proposed amendment to the 2020 Equity Incentive Plan would increase the annual per-participant share limit from 29,412 to 40,000 shares and the total shares reserved for issuance from 87,786 to 137,786.
• The company is classified as an 'emerging growth company' under federal securities laws.

Sentiment

Score: 6

Explanation: The filing details necessary corporate actions and capital-raising efforts, which are positive for continuity and growth. However, the significant potential for dilution from the ELOC and Series C financing, along with the anti-dilution provisions, introduces a notable negative aspect for existing shareholders. The management changes and board refreshment are generally positive for governance.

Positives

• The proposed ELOC amendment significantly enhances the company's ability to raise additional capital, increasing the commitment from $10 million to $50 million and extending the term to December 31, 2027.
• The completion of the Series C Preferred Stock and Warrants financing on June 30, 2025, secured $750,000 in gross proceeds, providing immediate capital.
• The board has been refreshed with three new independent directors (Nick Balletta, Emmanuel L. de Boucaud, Joshua Sroge) who bring diverse experience in technology, investment, and strategic finance.
• The proposed amendment to the 2020 Equity Incentive Plan aims to improve the company's ability to attract, retain, and motivate key personnel by increasing the share reserve and annual grant limits.
• The appointment of Joshua Sroge as an audit committee financial expert strengthens financial oversight.

Negatives

• The issuance of shares under the amended ELOC and from the conversion/exercise of Series C Preferred Stock and Warrants will have a dilutive effect on existing stockholders' voting power and economic rights.
• Future sales of common stock issued under these financing arrangements could adversely affect the prevailing market price of the company's shares or increase price volatility.
• The Series C Preferred Stock includes anti-dilution adjustments that could reduce the conversion and exercise prices below the Nasdaq Minimum Price, potentially leading to even greater dilution for existing shareholders.
• The Series C Preferred Stock dividend rate increases to 18% upon certain 'Triggering Events,' which could further burden the company or lead to more dilution if paid in common stock.
• Audit fees increased from $72,000 in 2023 to $91,000 in 2024, and 'All other fees' (related to potential acquisition targets and equity-related financing filings) significantly increased from $83,000 in 2023 to $139,793 in 2024.

Risks

• Significant dilution of existing stockholders' voting power and economic rights due to potential issuance of common stock under the expanded Equity Line of Credit and from the conversion of Series C Preferred Stock and exercise of Series C Warrants.
• Potential adverse impact on the company's stock price and increased volatility from future sales of shares issued under the ELOC and Series C financing.
• The Series C Preferred Stock's conversion price and Series C Warrants' exercise price are subject to downward anti-dilution adjustments, which could result in a greater number of shares being issued and further dilution.
• Risk of the dividend rate on Series C Preferred Stock increasing to 18% upon the occurrence of 'Triggering Events,' such as bankruptcy, failure to comply with Nasdaq listing rules, or breaches of transaction agreements.
• The company's ability to draw on the Equity Line of Credit is contingent on the SEC declaring a registration statement effective and other customary conditions being met.
• Failure to obtain stockholder approval for the ELOC amendment would limit the company's capital raising ability under that agreement to $10 million and terminate it by December 31, 2025.
• Failure to obtain stockholder approval for the Series C Preferred Issuance Proposal would limit the number of shares issuable upon conversion/exercise to 19.99% of outstanding shares, potentially impacting the company's ability to fully utilize the financing.
• Risk of not being able to attract and retain key personnel if the proposed amendment to the 2020 Equity Incentive Plan is not approved, potentially hindering the company's future success.

Future Outlook

The company aims to significantly enhance its ability to raise additional capital over the next several years by extending the term and increasing the commitment of its Equity Line of Credit. Management believes this flexibility in capital access will support business plans and generate stockholder value. Additionally, the proposed amendment to the Equity Incentive Plan is intended to improve the company's capacity to attract and retain key personnel, which is deemed crucial for future success.

Management Comments

• "The board believes that (i) extending the term of the Purchase Agreement and (ii) increasing the Commitment Amount from $10 million to $50 million will enhance the Company’s ability to raise additional capital over the next several years."
• "The board and the management of the Company believe that the potential to use the Equity Line of Credit would provide the Company flexibility in how it implements its business plans and ultimately generates value for its stockholders."
• "The board believes that the future success of the Company depends, in large part, upon our ability to attract, retain and motivate key personnel and that the granting of equity awards serves as an important factor in retaining key personnel."
• "The board believes that increasing the size of the share reserve of the 2020 Plan will improve the Company’s ability to grant appropriate and attractive equity incentive to key personnel."

Industry Context

This filing is a standard definitive proxy statement for an annual meeting, primarily focused on corporate governance, capital structure, and executive compensation. As an 'emerging growth company,' the company's actions, particularly regarding capital raises and equity incentives, are consistent with a growth-oriented business seeking to fund operations and attract talent. The document does not provide specific details on broader industry trends or competitive positioning beyond general corporate operations.

Management Changes

Corporate Governance

Related Party Transactions

• On April 17, 2023, the company entered into an additional Secured Bridge Note financing with Richard Minicozzi (a holder of more than 5% of common stock), receiving $750,000 in gross proceeds. The New Note had a principal of $825,000, a 10% interest rate, and a maturity date of July 31, 2023.
• In connection with the New Note, 1,530 common stock warrants were issued to Mr. Minicozzi with a five-year term and an $892.50 per share exercise price, with 765 immediately exercisable and the remainder becoming exercisable upon maturity extension.
• On July 31, 2023, the maturity date of the New Note was extended to November 30, 2023, and the interest rate increased to 20%.
• Amendments to a Prior Note financing with Mr. Minicozzi included canceling 706 common stock warrants and issuing 1,412 new common stock warrants with an $892.50 exercise price and a five-year term.
• On April 9, 2024, the company agreed to pay $2.75 million in cash to Mr. Minicozzi in repayment of the principal of the Bridge Notes (excluding original issue discount) after closing equity financings of at least $6,000,000.
• On April 26, 2024, the company repaid $2.75 million of principal on its Secured Bridge Notes.
• Effective April 9, 2024, Mr. Minicozzi converted $911,384 (unpaid accrued interest and original issue discount) into 27,256 prefunded common stock warrants ($0.001 exercise price) and 27,256 non-prefunded warrants (initial $33.439, adjusted to $6.2934).
• The company issued 2,942 new common stock warrants to Mr. Minicozzi as a loan extension fee, with an initial exercise price of $33.439 (adjusted to $6.2934).
• The exercise price of Mr. Minicozzi's Existing Warrants was adjusted from $259.25 to $33.439, and further to $6.2934.

Stakeholder Impact

• Shareholders: Face potential significant dilution from the proposed expansion of the Equity Line of Credit and the Series C Preferred Stock and Warrants financing, which could negatively impact their ownership percentage, voting power, and the market price of their shares. However, these capital raises are intended to fund operations and potentially generate long-term value.
• Employees and Management: The proposed amendment to the 2020 Equity Incentive Plan aims to provide more attractive equity incentives, which could improve employee retention and motivation.
• Creditors: The repayment of $2.75 million on Secured Bridge Notes to Richard Minicozzi demonstrates the company's commitment to fulfilling its debt obligations.

Next Steps

• Hold the 2025 Annual Meeting of Stockholders on September 8, 2025, to vote on the proposed matters.
• File a Current Report on Form 8-K with the SEC within four business days following the Annual Meeting to announce preliminary or final voting results.
• The company intends to hold its 2026 annual meeting in June or July 2026.
• The company plans to publicly announce the date of the 2026 annual meeting and the Rule 14a-8 deadline in early 2026.

Key Dates

Recommendation

The company is undertaking critical steps to secure future capital and align management incentives, which are positive for its operational continuity and growth prospects. However, the substantial potential for dilution from the expanded Equity Line of Credit and the Series C financing, coupled with the anti-dilution provisions that could further increase share count, introduces considerable risk for existing shareholders. The recent significant changes in board composition and CEO leadership suggest a period of strategic transition. Investors should hold to observe how the newly secured capital is deployed, how the dilution impacts the stock's market performance, and the effectiveness of the new leadership and governance structure in executing the company's business plans.

Keywords

Auddia Inc., SEC filing, proxy statement, annual meeting, corporate governance, Equity Line of Credit, ELOC, Series C Preferred Stock, convertible preferred stock, warrants, equity incentive plan, dilution, capital raise, Nasdaq, financial reporting, executive compensation, board of directors